title: Lower extremity nerve function, calf skeletal muscle characteristics, and functional performance in peripheral arterial disease.
abstract: OBJECTIVE
  To determine whether poor lower extremity nerve function is associated with less-favorable calf muscle characteristics and greater functional impairment in people with and without peripheral arterial disease (PAD).
  
  
  METHODS
  Cross-sectional.
  
  
  METHODS
  Three Chicago-area medical centers.
  
  
  METHODS
  Four hundred thirteen participants with PAD (ankle-brachial index (ABI) < 0.90) and 255 without.
  
  
  METHODS
  Electrodiagnostic testing of the peroneal nerve was performed. Calf muscle cross-sectional area and percentage fat were measured using computed tomography at 66.7% of the distance between the distal and proximal tibia. Six-minute walk performance was measured.
  
  
  RESULTS
  Adjusting for age, sex, race, ABI, leg symptoms, smoking, physical activity, comorbidities, and other covariates, lower peroneal nerve conduction velocity (NCV) was associated with lower calf muscle area (first quartile 4,770.3 mm(2) , fourth quartile 5,571 mm(2) , P < .001) and poorer 6-minute walk distance (first quartile 989.2 feet, fourth quartile 1,210.8 feet, P < .001) in participants without diabetes mellitus with PAD. Lower peroneal NCV was associated with lower calf muscle area (first quartile 5,166.0 mm(2) , fourth quartile 6,003.8 mm(2) , P = .01) and poorer 6-minute walk distance (first quartile 866.4 feet, fourth quartile 1,082.5 feet, P = .01) in participants with diabetes mellitus and PAD as well. In participants without PAD, lower peroneal NCV was not associated with lower calf muscle area but was associated with poorer 6-minute walk distance only in participants without diabetes mellitus (first quartile 1,317.0 feet, fourth quartile 1,570.4 feet, P-trend < .001).
  
  
  CONCLUSIONS
  Lower peroneal nerve function is associated with smaller calf muscle area and greater functional impairment in individuals with PAD. Future study is needed to determine whether improving peroneal NCV prevents loss of calf muscle and functional decline in people with PAD.
authors.affiliation: Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
authors.forename: Parveen K
authors.initials: PK
authors.lastname: Garg
authors.forename: Kiang
authors.initials: K
authors.lastname: Liu
authors.forename: Luigi
authors.initials: L
authors.lastname: Ferrucci
authors.forename: Jack M
authors.initials: JM
authors.lastname: Guralnik
authors.forename: Michael H
authors.initials: MH
authors.lastname: Criqui
authors.forename: Lu
authors.initials: L
authors.lastname: Tian
authors.forename: Robert
authors.initials: R
authors.lastname: Sufit
authors.forename: Takashi
authors.initials: T
authors.lastname: Nishida
authors.forename: Huimin
authors.initials: H
authors.lastname: Tao
authors.forename: Yihua
authors.initials: Y
authors.lastname: Liao
authors.forename: Mary M
authors.initials: MM
authors.lastname: McDermott
mesh_terms: D000368:Aged; D055109:Ankle Brachial Index; D001157:Arterial Occlusive Diseases / Q000175:diagnosis / Q000503:physiopathology*; D015897:Comorbidity; D003430:Cross-Sectional Studies; D003925:Diabetic Angiopathies / Q000175:diagnosis / Q000503:physiopathology*; D004185:Disability Evaluation; D005080:Exercise Test; D005260:Female; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008019:Life Style; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000294:innervation* / Q000503:physiopathology*; D009133:Muscular Atrophy / Q000175:diagnosis / Q000503:physiopathology; D009431:Neural Conduction / Q000502:physiology*; D009460:Neurologic Examination; D010543:Peroneal Nerve / Q000503:physiopathology*; D013223:Statistics as Topic; D013497:Sural Nerve / Q000503:physiopathology
references.citation: J Gen Intern Med. 2001 Jun;16(6):384-90
references.pmid: 11422635
references.citation: J Am Coll Cardiol. 2004 Aug 4;44(3):618-23
references.pmid: 15358030
references.citation: Arthritis Rheum. 1991 May;34(5):505-14
references.pmid: 2025304
references.citation: Circulation. 1993 Feb;87(2):413-21
references.pmid: 8425290
references.citation: Diabetes Care. 2000 Nov;23(11):1642-7
references.pmid: 11092286
references.citation: J Neurol Neurosurg Psychiatry. 1958 May;21(2):109-18
references.pmid: 13539652
references.citation: N Engl J Med. 1995 Mar 2;332(9):556-61
references.pmid: 7838189
references.citation: Eur J Vasc Surg. 1989 Aug;3(4):315-22
references.pmid: 2767254
references.citation: Bull Johns Hopkins Hosp. 1950 May;86(5):265-90
references.pmid: 15414383
references.citation: Can Med Assoc J. 1985 Apr 15;132(8):919-23
references.pmid: 3978515
references.citation: J Vasc Surg. 2004 Mar;39(3):523-30
references.pmid: 14981443
references.citation: Arch Intern Med. 2006 Oct 9;166(18):1986-92
references.pmid: 17030832
references.citation: Arthritis Rheum. 1986 Aug;29(8):1039-49
references.pmid: 3741515
references.citation: J Appl Physiol (1985). 1998 Jul;85(1):115-22
references.pmid: 9655763
references.citation: J Am Geriatr Soc. 2005 Feb;53(2):198-203
references.pmid: 15673341
references.citation: JAMA. 2001 Oct 3;286(13):1599-606
references.pmid: 11585483
references.citation: J Gerontol. 1994 Mar;49(2):M85-94
references.pmid: 8126356
references.citation: J Am Geriatr Soc. 2002 Feb;50(2):247-55
references.pmid: 12028205
references.citation: JAMA. 2004 Jul 28;292(4):453-61
references.pmid: 15280343
references.citation: Diabetes Care. 2008 Sep;31(9):1767-72
references.pmid: 18535192
references.citation: J Vasc Surg. 2007 Jul;46(1):87-93
references.pmid: 17540532
references.citation: Vasc Med. 2007 Nov;12(4):285-90
references.pmid: 18048464
references.citation: Ann Intern Med. 2002 Jun 18;136(12):873-83
references.pmid: 12069561
references.citation: J Am Geriatr Soc. 2007 Mar;55(3):400-6
references.pmid: 17341243
references.citation: Neurology. 1992 May;42(5):994-9
references.pmid: 1579257
references.citation: J Am Geriatr Soc. 1998 Jun;46(6):706-11
references.pmid: 9625185